{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:08:58Z","timestamp":1780391338441,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T00:00:00Z","timestamp":1343174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00296-012-2458-5","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T09:15:21Z","timestamp":1343121321000},"page":"939-942","source":"Crossref","is-referenced-by-count":31,"title":["The frequency of antibodies against cyclic citrullinated peptides and rheumatoid factor in healthy population: a field study of rheumatoid arthritis from northern turkey"],"prefix":"10.1007","volume":"33","author":[{"given":"Turker","family":"Tasliyurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunyamin","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suheyla Uzun","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beytullah","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk","family":"Kutluturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Ozyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semsettin","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"2458_CR1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","volume":"4","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4:130\u2013136","journal-title":"Autoimmun Rev"},{"key":"2458_CR2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903\u2013911","journal-title":"Lancet"},{"issue":"659","key":"2458_CR3","first-page":"672","volume":"373","author":"L Klareskog","year":"2009","unstructured":"Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373(659):672","journal-title":"Lancet"},{"key":"2458_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"2458_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/rheumatology\/kei228","volume":"45","author":"MR Westwood","year":"2006","unstructured":"Westwood MR, Nelson PN, Hay FC (2006) Rheumatoid factors: what\u2019s new? Rheumatology 45:379\u2013385","journal-title":"Rheumatology"},{"key":"2458_CR6","first-page":"15","volume":"21","author":"AN Lee","year":"2008","unstructured":"Lee AN, Beck CE, Hall M (2008) Rheumatoid factor and anti-CCP antibodies in rheumatoid arthritis: a review. Clin Lab Sci 21:15\u201318","journal-title":"Clin Lab Sci"},{"key":"2458_CR7","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"2458_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"2458_CR9","first-page":"416","volume":"22","author":"S Akar","year":"2004","unstructured":"Akar S, Birlik M, Guler O et al (2004) The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 22:416\u2013420","journal-title":"Clin Exp Rheumatol"},{"key":"2458_CR10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10067-004-1006-4","volume":"24","author":"C Kacar","year":"2005","unstructured":"Kacar C, Gilgil E, Tuncer T et al (2005) Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24:212\u2013214","journal-title":"Clin Rheumatol"},{"issue":"4","key":"2458_CR11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1756-185X.2010.01562.x","volume":"13","author":"E Capkin","year":"2010","unstructured":"Capkin E, Cakirbay H, Karkucak M et al (2010) Prevalence of rheumatoid arthritis in the eastern Black Sea region of Turkey. Int J Rheum Dis 13(4):380\u2013384","journal-title":"Int J Rheum Dis"},{"key":"2458_CR12","doi-asserted-by":"crossref","unstructured":"Cak\u0131r N, Pamuk \u00d6N, Dervi\u015f E et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32(4):895\u2013908","DOI":"10.1007\/s00296-010-1699-4"},{"issue":"4","key":"2458_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar95","volume":"2","author":"WJ Venrooij Van","year":"2000","unstructured":"Van Venrooij WJ, Pruijn GJ (2000) Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2(4):249\u2013251","journal-title":"Arthritis Res"},{"issue":"6","key":"2458_CR14","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.23514","volume":"58","author":"P Kakumanu","year":"2008","unstructured":"Kakumanu P, Yamagata H, Sobel ES et al (2008) Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 58(6):1576\u20131581","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2458_CR15","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3899\/jrheum.090338","volume":"36","author":"P Kakumanu","year":"2009","unstructured":"Kakumanu P, Sobel ES, Narain S et al (2009) Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming\/erosive arthritis. J Rheumatol 36(12):2682\u20132690","journal-title":"J Rheumatol"},{"issue":"1","key":"2458_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","volume":"64","author":"JE Gottenberg","year":"2005","unstructured":"Gottenberg JE, Mignot S, Nicaise-Rolland P et al (2005) Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 64(1):114\u2013117","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2458_CR17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10067-006-0313-3","volume":"26","author":"F Ingegnoli","year":"2007","unstructured":"Ingegnoli F, Galbiati V, Zeni S et al (2007) Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 26(4):510\u2013514","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2458_CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10165-004-0325-2","volume":"14","author":"Y Takasaki","year":"2004","unstructured":"Takasaki Y, Yamanaka K, Takasaki C et al (2004) Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod Rheumatol 14(5):367\u2013375","journal-title":"Mod Rheumatol"},{"issue":"2","key":"2458_CR19","first-page":"99","volume":"50","author":"T Li","year":"2011","unstructured":"Li T, Bao J, Yin J et al (2011) The specificity of anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis from a large cohort study in the Chinese. Zhonghua Nei Ke Za Zhi. 50(2):99\u2013101","journal-title":"Zhonghua Nei Ke Za Zhi."},{"issue":"8","key":"2458_CR20","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/rheumatology\/keq134","volume":"49","author":"I Goeldner","year":"2010","unstructured":"Goeldner I, Skare TL, de Messias Reason IT et al (2010) Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology (Oxford) 49(8):1590\u20131593","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"2458_CR21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65(7):845\u2013851","journal-title":"Ann Rheum Dis"},{"key":"2458_CR22","first-page":"1968","volume-title":"Harrison\u2019s 16th edition Principles of \u0130nternal Medicine","author":"PE Lipsky","year":"2005","unstructured":"Lipsky PE (2005) Rheumatoid arthritis. In: Braunwald E (ed) Harrison\u2019s 16th edition Principles of \u0130nternal Medicine. Mc Graw Hill, New York, pp 1968\u20131976"},{"key":"2458_CR23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA\u2013DR (shared epitope)\u2013restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38\u201346","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2458-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2458-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:39Z","timestamp":1559028099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2458-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2458"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2458-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}